Your Patient Can't Find Anagrelide — Here's How You Can Help

When a patient with essential thrombocythemia calls your office because they can't fill their Anagrelide prescription, it's more than an inconvenience — it's a clinical concern. Abrupt discontinuation of Anagrelide can cause rapid platelet count rebound, increasing the risk of thrombotic events. As a prescriber, you're uniquely positioned to help navigate availability challenges and keep your patients on therapy.

This guide outlines practical steps your practice can take to help patients locate Anagrelide and maintain treatment continuity.

Current Availability: What You Need to Know

Anagrelide hydrochloride capsules (0.5 mg and 1 mg) are currently manufactured primarily by Teva, with the brand-name Agrylin from Shire (Takeda) having limited availability. Key points:

• Generic supply from Teva is ongoing but not uniformly distributed to all retail locations
• Large chain pharmacies may not routinely stock Anagrelide due to low fill volume
• Independent and specialty pharmacies typically have better access through diversified wholesaler relationships
• ASHP has documented intermittent shortages since Mylan's 2015 discontinuation

For full shortage context and timeline, see our provider shortage briefing for 2026.

Why Patients Can't Find Anagrelide

Understanding the root causes helps you counsel patients effectively:

1. Limited manufacturer diversity: Mylan's 2015 exit left fewer generic producers, making the supply chain more fragile
2. Low-volume stocking decisions: Retail chains stock based on fill frequency — a medication for a rare hematologic condition often doesn't make the cut
3. Regional distribution variation: A drug can be "available" nationally but absent from pharmacies in your patient's area
4. Ordering delays: Even when pharmacies can order Anagrelide, special orders may take 2-5 business days

What Providers Can Do: 5 Practical Steps

Step 1: Direct Patients to the Right Pharmacy Type

Your first recommendation matters. Instead of letting patients cycle through chain pharmacies, direct them to:

• Specialty pharmacies with hematology/oncology focus — they routinely stock niche medications like Anagrelide
• Independent community pharmacies — they often work with multiple wholesalers and can order quickly
• Medfinder for Providers — a real-time tool that shows which pharmacies in the patient's area have Anagrelide in stock

Step 2: Prescribe 90-Day Supplies

When clinically appropriate and permitted by insurance, writing for a 90-day supply:

• Reduces fill frequency and the number of times patients must search for stock
• Provides a buffer against short-term supply disruptions
• May lower per-unit cost depending on pharmacy and insurance plan

Step 3: Establish a Proactive Refill Workflow

Build reminder systems into your practice:

• Flag Anagrelide patients for early refill outreach (at the 21-day mark of a 30-day supply)
• Include pharmacy availability check as part of follow-up visit workflow
• Document the patient's preferred pharmacy and a backup pharmacy in the chart

Step 4: Maintain Familiarity with Alternative Agents

When Anagrelide is temporarily unavailable, be prepared to pivot:

• Hydroxyurea: First-line cytoreductive therapy, widely available, affordable (often under $20/month generic). The PT-1 trial supports its use with low-dose aspirin in high-risk ET.
• Pegylated Interferon Alfa-2a (Pegasys): Preferred for younger patients; potential disease-modifying effects. Weekly subcutaneous injection.
• Ruxolitinib (Jakafi): Off-label for refractory ET; costly and may face insurance barriers.
• Busulfan: Last-line option for older patients. Leukemogenic risk with prolonged use.

If transitioning a patient, plan for overlapping therapy and weekly CBC monitoring during the transition period. More details in our patient alternatives guide.

Step 5: Help Patients Address Cost Barriers

Even when Anagrelide is available, cost can be a barrier — retail price without insurance is approximately $481 for 60 capsules (0.5 mg). Point patients toward:

• Discount cards: GoodRx and SingleCare can bring the cost down to $48-$91 for 60 capsules
• Prescription Hope: Patient assistance at $70/month
• NeedyMeds and RxAssist: Databases of manufacturer and foundation assistance programs

For a comprehensive financial resource, see our provider's guide to helping patients save on Anagrelide.

Workflow Tips for Your Practice

Integrating Anagrelide availability management into your clinical workflow doesn't have to be complicated:

• Create a shared document listing local pharmacies that reliably stock Anagrelide — update it monthly
• Designate a staff member (MA, nurse, or pharmacy liaison) to handle availability calls when patients report stock-outs
• Bookmark Medfinder for Providers on office computers for quick pharmacy stock lookups
• Set EHR alerts for patients on Anagrelide to prompt availability conversations at each visit
• Maintain a small sample stock if available through your pharmaceutical representative — even a few days' bridge supply can prevent dangerous treatment gaps

Final Thoughts

Anagrelide availability challenges are unlikely to resolve completely until additional manufacturers enter the market. In the meantime, prescribers play a critical role in bridging access gaps for their patients. Proactive pharmacy routing, 90-day prescriptions, staff workflows, and familiarity with alternatives can make the difference between a missed dose and uninterrupted therapy.

Use Medfinder for Providers as part of your toolkit, and share our patient resources — including how to find Anagrelide in stock and how to save money on Anagrelide — with your patients to empower them between visits.